Active pharmaceutical ingredients under development
Product Name
CAS Number
Specification
TP
DMF
Status
Lotilaner
1369852-71-0
Q4 2025
Q2 2026
Luseogliflozin Hydrate
898537-18-3
Q4 2025
Q2 2026
Mirogabalin Besylate
1138245-21-2
Q3 2025
Q1 2026
Nirogacestat hydrobromide
1962925-29-6
Q4 2025
Q2 2026
Relugolix
737789-87-6
Q4 2025
Q2 2026
Rufinamide
106308-44-5
Q4 2025
Q2 2026
Scopolamine Hydrobromide
114-49-8
Q3 2025
Q1 2026
Seladelpar
851528-79-5
Q3 2026
Q2 2027
SNAC
203787-91-1
Q3 2025
Q4 2025
Tofogliflozin
1201913-82-7
Q4 2025
Q2 2026
1-(Perfluorohexyl)octane
133331-77-8
Q42025
Q2 2026